Abstract No. 451 Reversal of the Warburg Phenotype by Promotion of Pyruvate Dehydrogenase Activity Decreases Hepatocellular Carcinoma Resistance to Targeted Anti-Cancer Therapies

Journal of Vascular and Interventional Radiology - United States
doi 10.1016/j.jvir.2018.01.496
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Targeted Therapies in Cancer and Mechanisms of Resistance

Journal of Molecular Medicine
Molecular MedicineDrug DiscoveryGenetics
2014English

Liver Targeted Therapies for Hepatocellular Carcinoma Prior to Transplant: Contemporary Management Strategies

Global Surgery
2017English

Promotion of Hepatocellular Carcinoma by Hepatitis C Virus

Digestive Diseases
MedicineGastroenterology
2012English

RRAD Suppresses the Warburg Effect by Downregulating ACTG1 in Hepatocellular Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2019English

SIRT3 Deacetylates and Increases Pyruvate Dehydrogenase Activity in Cancer Cells

Free Radical Biology and Medicine
BiochemistryPhysiology
2014English

Phenylbutyrate Increases Activity of Pyruvate Dehydrogenase Complex.

Oncotarget
Oncology
2013English

Targeted Cancer Therapies

Chinese Journal of Cancer
2011English

Sirtuin 3-Mediated Pyruvate Dehydrogenase Activity Determines Brown Adipocytes Phenotype Under High-Salt Conditions

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2019English

Pyruvate Dehydrogenase Kinase Is a Metabolic Checkpoint for Polarization of Macrophages to the M1 Phenotype

Frontiers in Immunology
AllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy